Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Drug Discovery: Overview01:26

Drug Discovery: Overview

11.1K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
11.1K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.7K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.7K
Drug Clearance: Overview01:06

Drug Clearance: Overview

386
Drug elimination refers to drug removal from the body, either through urine or bile, by the kidneys or liver, respectively. A pharmacokinetic parameter, drug clearance, measures the efficiency of drug removal from the bloodstream within a specific time frame. It is calculated as the rate at which a drug is eliminated from plasma divided by the drug's concentration in plasma.
Drug clearance is not limited to renal excretion but encompasses all organs involved in drug elimination, including...
386
Preclinical Development: Overview01:28

Preclinical Development: Overview

5.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.8K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

10.1K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.1K
Drug Delivery: Overview01:16

Drug Delivery: Overview

730
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
730

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Property-Based Drug Design Merits a Nobel Prize.

Journal of medicinal chemistry·2024
Same author

Catalytic intramolecular aminoarylation of unactivated alkenes with aryl sulfonamides.

Chemical science·2022
Same author

Arene dearomatization through a catalytic N-centered radical cascade reaction.

Nature communications·2020
Same author

Arylsulfonylacetamides as bifunctional reagents for alkene aminoarylation.

Science (New York, N.Y.)·2018
Same journal

Metal-Drug Complexes as Long-Release Application for Antimalarial PfFNT-Inhibitors.

ChemMedChem·2026
Same journal

Speciation Studies of Monosubstituted Pt, Mo, and W Decavanadates in Culture Media and In Vitro Activity Against Trypanosoma cruzi.

ChemMedChem·2026
Same journal

Novel Xanthene Derivatives for Neuroprotection in Alzheimer's Disease-Synthesis and Biological Assessment.

ChemMedChem·2026
Same journal

Discovery of a New Scaffold RSK2 Inhibitor With Virtual and Phenotypical Screening.

ChemMedChem·2026
Same journal

Levoglucosenone-Derived Isothiocyanates as Antifungal Compounds: Merging Sustainability and Medicinal Chemistry.

ChemMedChem·2026
Same journal

Bacterial Ghosts as Innovative Transport Vehicles for Platinum-Based Anticancer Drugs.

ChemMedChem·2026
查看所有相关文章

相关实验视频

Updated: Jan 18, 2026

Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish
07:50

Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish

Published on: July 16, 2012

14.7K

通过知识共享加速药物发现.

Rory C McAtee1

  • 1Drug Hunter Inc., 111 SW 5th Ave, Ste 3150, Portland, OR, 97204-3656, USA.

ChemMedChem
|January 17, 2026
PubMed
概括
此摘要是机器生成的。

通过可访问的枢纽和编码的启发式方法,在药物发现中有效的知识共享提高了研发效率和成功率. 这种方法将信息捕获整合到日常工作流程中,缩短时间表和制度化专业知识.

关键词:
合作平台 合作平台 合作平台集体情报是一种集体情报.发现药物的发现.机构记忆 机构记忆知识管理知识管理知识管理翻译的研发工作.

更多相关视频

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.2K
Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

5.4K

相关实验视频

Last Updated: Jan 18, 2026

Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish
07:50

Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish

Published on: July 16, 2012

14.7K
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.2K
Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

5.4K

科学领域:

  • 药物发现和开发 药物发现和开发
  • 在科学领域的知识管理.
  • 计算化学计算化学

背景情况:

  • 现代药物发现面临重大挑战,包括高消耗率,复杂的目标和不断上升的研发成本.
  • 目前的研发模式受到不充分的知识共享,科学和财务风险增加的阻碍.
  • 有效的知识管理对于提高制药研究成功概率至关重要.

研究的目的:

  • 探索知识共享工具和文化对药物发现效率的影响.
  • 突出成功的知识管理系统及其好处.
  • 讨论将知识共享纳入研发工作流程和人类系统的整合.

主要方法:

  • 审查制药行业现有的知识共享平台和战略.
  • 分析了来自瑞,罗氏和阿斯特拉泽内卡等公司的案例研究.
  • 讨论编码启发式的作用和外部知识流.

主要成果:

  • 可访问的知识中心 (例如,OnePoint,Pfizerpedia) 和以化学为中心的平台 (例如,罗氏的知识幻灯片) 促进信息捕获.
  • 与QSAR模型和DMTA循环跟踪集成的AstraZeneca的化合物设计数据库 (CDD) 减少了50%的想法到化合物的时间.
  • 编码式启发式,像药物大师的转换,制度化专家知识和辅助培训.

结论:

  • 整合知识共享工具和培养支持性文化对于克服药物发现挑战至关重要.
  • 将信息捕获嵌入日常工作并同步研发流程的系统可以显著提高效率.
  • 知识共享的长期成功取决于强大的人类系统,包括网络,激励和精心策划的信息流.